Skip to main content

Part of cannabis and small business and retail

Canadian cannabis producer Tilray Inc reported an 86 per cent jump in third-quarter revenue on Tuesday, but a wider-than-expected loss weighed on shares in after-hours trading.

Revenue rose to $10-million ($13.24-million) in the three months ended Sept. 30, the Nanaimo, British Columbia-based company said in a statement.

But the company’s net loss grew to $18.7-million, or 20 cents a share, from $1.8-million, or 2 cents, in the year-ago period. Analysts had expected a loss of $12.7-million.

Story continues below advertisement

Tilray’s biggest expense was $11.2-million for stock-based compensation, according to its statement.

Shares of Canada’s most highly valued cannabis producer, which listed on the Nasdaq in July, initially rose in after-hours trade, but were last down 4.1 per cent to $106.05.

The stock had closed 1.7 per cent lower at $111.55 on Tuesday, compared with its initial public offering price of $17.

Tilray and other Canadian cannabis firms have been ramping up production at home and expanding overseas to position themselves for legalization of recreational use in Canada and approvals of medical use around the world.

The reporting period also preceded the Oct. 17 start of legal sales of recreational cannabis in Canada.

Tilray has agreements with eight Canadian provinces to supply their recreational cannabis markets. It also sells medical marijuana products on its own, with partners or through export deals, in countries including Australia, Germany, Portugal, Argentina, Chile, South Africa and Britain.

Tilray said total kilogram equivalents of cannabis sold surged over twofold in the quarter to 1,613 kilograms. The average selling price per gram fell to $6.21 from $7.53 a year earlier, as higher bulk sales pushed down margins.

Story continues below advertisement

Gross margins fell to 31 per cent from 55 per cent a year ago, the company said.

Available now: Cannabis Professional, the authoritative e-mail newsletter tailored specifically for professionals in the rapidly evolving cannabis industry. Subscribe now.

Report an error
Tickers mentioned in this story
Unchecking box will stop auto data updates
Comments

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • All comments will be reviewed by one or more moderators before being posted to the site. This should only take a few moments.
  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed. Commenters who repeatedly violate community guidelines may be suspended, causing them to temporarily lose their ability to engage with comments.

Read our community guidelines here

Discussion loading ...

Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.
Cannabis pro newsletter